Whole Orbital Tissue Culture Identifies Imatinib Mesylate and Adalimumab as Potential Therapeutics for Graves' Ophthalmopathy

British Journal of Ophthalmology - United Kingdom
doi 10.1136/bjo.2010.192302
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Current and Future Treatments for Graves’ Disease and Graves’ Ophthalmopathy

Hormone and Metabolic Research
BiochemistryEndocrinologyClinical BiochemistryMedicineMetabolismDiabetes
2018English

Expression of Cyclooxygenase-2 in Orbital Fibroadipose Connective Tissues of Graves' Ophthalmopathy Patients

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2006English

Platelet-Derived Growth Factor-Bb: A Stimulus for Cytokine Production by Orbital Fibroblasts in Graves' Ophthalmopathy

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2010English

Evidence for Enhanced Thy-1 (CD90) Expression in Orbital Fibroblasts of Patients With Graves' Ophthalmopathy

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2008English

Blepharoplasty in Graves' Ophthalmopathy

Craniomaxillofacial Trauma & Reconstruction Open
2017English

Corneal Astigmatism in Graves' Ophthalmopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2005English

Quality of Life in Patients With Graves Ophthalmopathy

American Journal of Ophthalmology
Ophthalmology
2006English

Stem Cell Factor Deficiency Is Vasculoprotective: Unraveling a New Therapeutic Potential of Imatinib Mesylate

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2006English

Lid Lengthening by Sclera Interposition for Eyelid Retraction in Graves' Ophthalmopathy.

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy